CREO.L (CREO.L) News
Track canonical SquawkNews coverage tagged to CREO.L, CREO.L. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Creo Medical (CREO.L) expects FY revenue growth of 50%-60% in line with guidance
Reuters says Creo Medical is confident of delivering FY revenue growth of 50% to 60% and expects Q3-26 year-to-date revenue growth of about 50%. H1 adjusted EBIT was GBP -4.9 million.
EARNINGS | Sep 30, 2026, 07:05 AM UTC
M
Creo Medical H1 revenue rises 45% as loss narrows; expects full-year growth of 50% to 60%
Creo Medical said H1-26 revenue rose 45% year on year, operating loss narrowed by over 25% to £4.9 million, and it expects full-year revenue growth of 50% to 60%.
EARNINGS | Sep 30, 2026, 06:16 AM UTC